Sort by
Refine Your Search
-
, create, test and deliver transformative medicines to treat patients who suffer from genetic diseases. BridgeBio's pipeline of development programs ranges from early science to advanced clinical trials
-
analyze glucose levels. Our science-driven products empower people living with diabetes. Through our innovative product development program, Abbott has developed many cutting-edge glucose monitoring
-
development and post-marketing research, HCP and patient interactions, scientific publications, field materials, sponsorships, grants. Fellow activity will often involve working cross-functionally with teams
-
of a Masters degree in a technical field or extensive government or industry experience. Significant professional experience in cybersecurity, healthcare technology, embedded systems, or related
-
starting Fall 2026. The postdoctoral scholar will work directly with Dr. Idia Binitie Thurston, Professor of Public Health & Health Sciences and Applied Psychology; Affiliate Professor of Africana Studies
-
biology, including neuropathic pain, APOL1-mediated kidney disease, IgA nephropathy, primary membranous, nephropathy, autosomal dominant polycystic kidney disease, type 1 diabetes, and myotonic dystrophy
-
in medical information, medical communications & publications, field-based US medical science liaison and promotional review committee and will also have the opportunity to specialize in a preferred
-
the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach
-
Derived Therapy fellowship, based in Cambridge, MA. About Takeda Takeda has been translating science into breakthrough medicines for 240 years. Every step of the way, our teams have worked together
-
the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach